Used in biomedical research to quantify levels of active Tumor Necrosis Factor Alpha Convertase (TACE) in cell culture supernatants, serum, and plasma samples. Enables researchers to study TACE involvement in inflammatory processes, cancer progression, and autoimmune diseases. Supports drug development by assessing inhibitor efficacy in modulating TACE activity. Provides a reliable, sensitive, and high-throughput method for screening therapeutic compounds targeting TNF-α signaling pathways. Widely applied in immunology, oncology, and pharmaceutical research settings.